The development marks a shift up the value chain for labs and could prove a meaningful revenue stream for providers able to ...

Through clinical trials, partnerships, and economic studies, a crop of test developers is trying to prove the value of their ...

The Uppsala University spinout aims to use its SuperRCA mutation detection technology for applications including molecular residual disease monitoring.

The test, which Santa Maria, California-based Hardy distributes in the US under a license from NG Biotech, is designed to detect CTX-M enzymes.